Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lyell Immunopharma, Inc. | 50,000 | reported | 10 Feb 2026 | tx 2+150,000 |
| Audentes Therapeutics, Inc. | 0 | reported | 15 Jan 2020 | tx 5+141,333−141,333 |
| Kinnate Biopharma Inc. | 0 | reported | 03 Apr 2024 | tx 16+475,000−986,949 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Feb 2026 | GRANT_AWARD | Lyell Immunopharma, Inc. | 50,000 | 0.00 USD | deriv |
| 09 Jun 2025 | GRANT_AWARD | Lyell Immunopharma, Inc. | 100,000 | 0.00 USD | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 27,578 | — | |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 100,000 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 384,508 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 135,000 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 215,000 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 121,503 | — | deriv |
| 01 Mar 2024 | TAX_WITHHOLDING | Kinnate Biopharma Inc. | 558 | 2.59 USD | |
| 01 Dec 2023 | TAX_WITHHOLDING | Kinnate Biopharma Inc. | 541 | 2.25 USD | |
| 01 Sept 2023 | TAX_WITHHOLDING | Kinnate Biopharma Inc. | 541 | 2.35 USD | |
| 01 Jun 2023 | TAX_WITHHOLDING | Kinnate Biopharma Inc. | 541 | 4.30 USD | |
| 01 Mar 2023 | TAX_WITHHOLDING | Kinnate Biopharma Inc. | 638 | 5.21 USD | |
| 10 Feb 2023 | GRANT_AWARD | Kinnate Biopharma Inc. | 215,000 | 0.00 USD | deriv |
| 01 Dec 2022 | TAX_WITHHOLDING | Kinnate Biopharma Inc. | 541 | 7.75 USD | |
| 01 Sept 2022 | GRANT_AWARD | Kinnate Biopharma Inc. | 25,000 | 0.00 USD | |
| 11 Feb 2022 | GRANT_AWARD | Kinnate Biopharma Inc. | 135,000 | 0.00 USD | deriv |
| 12 Feb 2021 | GRANT_AWARD | Kinnate Biopharma Inc. | 100,000 | 0.00 USD | deriv |
| 15 Jan 2020 | TENDER | Audentes Therapeutics, Inc. | 32,705 | 60.00 USD | |
| 15 Jan 2020 | OTHER | Audentes Therapeutics, Inc. | 104,000 | — | deriv |
| 12 Dec 2019 | TAX_WITHHOLDING | Audentes Therapeutics, Inc. | 4,628 | 59.37 USD | |
| 28 Mar 2019 | GRANT_AWARD | Audentes Therapeutics, Inc. | 37,333 | 0.00 USD | |
| 28 Mar 2019 | GRANT_AWARD | Audentes Therapeutics, Inc. | 104,000 | 0.00 USD | deriv |